|

LY3841136 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Eloralintide

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Hepatic Insufficiency1
  • Liver Disease1

Orlando, Florida1 trial

A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Orlando Clinical Research Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.